Citation Impact
Citing Papers
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
2020 StandoutScience
A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein
2007 StandoutNobel
Mapping the Antigenic and Genetic Evolution of Influenza Virus
2004 StandoutScience
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Characterization of a canine homolog of hepatitis C virus
2011 StandoutNobel
Polypeptide synthesis in influenza virus-infected cells
1972
Inverting family GH156 sialidases define an unusual catalytic motif for glycosidase action
2019 StandoutNobel
Bacterial glycosyltransferase-mediated cell-surface chemoenzymatic glycan modification
2019 StandoutNobel
The Genesis and Spread of Reassortment Human Influenza A/H3N2 Viruses Conferring Adamantane Resistance
2007
H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes
2002
Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine
2004
Influenza and the Winter Increase in Mortality in the United States, 1959-1999
2004
Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent
2003
Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems
1998
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Determination of Neuraminidase Kinetic Constants Using Whole Influenza Virus Preparations and Correction for Spectroscopic Interference by a Fluorogenic Substrate
2013
Defense against Influenza A Virus Infection: Essential Role of the Chemokine System
2001
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 StandoutNobel
Influenza vaccine: The challenge of antigenic drift
2007
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus
1998
Antiviral agents active against influenza A viruses
2006
Coronavirus as a possible cause of severe acute respiratory syndrome
2003 Standout
Transmission of Influenza: Implications for Control in Health Care Settings
2003
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Use of the Inactivated Intranasal Influenza Vaccine and the Risk of Bell's Palsy in Switzerland
2004 Standout
Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.
1994 StandoutNobel
An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence
2010 StandoutNobel
Absolute Humidity and Pandemic Versus Epidemic Influenza
2010
Computational design of trimeric influenza-neutralizing proteins targeting the hemagglutinin receptor binding site
2017 StandoutNobel
Infections in Patients with Diabetes Mellitus
1999 Standout
Role of Hemagglutinin Cleavage for the Pathogenicity of Influenza Virus
1999
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
2020 Standout
Pandemic versus Epidemic Influenza Mortality: A Pattern of Changing Age Distribution
1998
Ecological and immunological determinants of influenza evolution
2003 Nature
Effectiveness of Pneumococcal Polysaccharide Vaccine in Older Adults
2003
A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice
2000
Strategies for mitigating an influenza pandemic
2006 StandoutNature
Genetic analysis of two influenza A (H1) swine viruses isolated from humans in Thailand and the Philippines
2007
Actual Causes of Death in the United States, 2000
2004 Standout
Environmental Conditions Affect Exhalation of H3N2 Seasonal and Variant Influenza Viruses and Respiratory Droplet Transmission in Ferrets
2015
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Safety and Immunogenicity of Intranasally Administered Inactivated Trivalent Virosome‐Formulated Influenza Vaccine ContainingEscherichia coliHeat‐Labile Toxin as a Mucosal Adjuvant
2000
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
TMEM41B Is a Pan-flavivirus Host Factor
2020 StandoutNobel
Climate change and human health: present and future risks
2006 Standout
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
2020 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells
2001
Mapping unintegrated avian sarcoma virus DNA: Termini of linear DNA bear 300 nucleotides present once or twice in two species of circular DNA
1978 StandoutNobel
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
1997 Standout
Induction of virus-specific modifications recognized by cytotoxic T cells is not altered by prior substitution of target cells with trinitrophenol.
1977 StandoutNobel
Characterization of a Novel Influenza A Virus Hemagglutinin Subtype (H16) Obtained from Black-Headed Gulls
2005
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis
2005
Prevention and Control of Seasonal Influenza with Vaccines
2016
The polypeptides of influenza virus
1972
Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli.
1983
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Unmutated Immunoglobulin M Can Protect Mice from Death by Influenza Virus Infection
2003 StandoutNobel
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans
2009 Standout
Pathogen Genomics in Public Health
2019
Insights into the Interaction between Influenza Virus and Pneumococcus
2006
Mechanisms of mouse spleen dendritic cell function in the generation of influenza-specific, cytolytic T lymphocytes.
1992 StandoutNobel
Overexpression of the α-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors
2003
Cell-mediated immune response to influenza virus infections in mice
1976
Global Patterns of Influenza A Virus in Wild Birds
2006 StandoutScience
Innate Defense against Influenza A Virus: Activity of Human Neutrophil Defensins and Interactions of Defensins with Surfactant Protein D
2006
Nucleotide sequences of influenza virus segments 1 and 3 reveal mosaic structure of a small viral RNA segment
1982 StandoutNobel
Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses.
1977 StandoutNobel
Predicting adaptive evolution
2001
Generation of both cross-reactive and virus-specific T-cell populations after immunization with serologically distinct influenza A viruses.
1977 StandoutNobel
Synthesis of an ochre suppressor tRNA gene and expression in mammalian cells.
1984 StandoutNobel
Isolation of neuraminidase from the WSN strain of influenza virus
1972
Adaptive strategies of the influenza virus polymerase for replication in humans
2009 StandoutNobel
Potential Impact of Antiviral Drug Use during Influenza Pandemic
2005
Mumefural and related HMF derivatives from Japanese apricot fruit juice concentrate show multiple inhibitory effects on pandemic influenza A (H1N1) virus
2010
The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host
2005
Early events in influenza virus infection III. The formation of a nucleoplasmic ribonucleoprotein complex from the input virion
1978
Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus
2002
Influenza virus structural and nonstructural proteins in infected cells and their plasma membranes
1971
Guidelines for Preventing Health-Care-Associated Pneumonia, 2003: Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee
2004 Standout
Structure of the neuraminidase gene in human influenza virus A/PR/8/34
1981 StandoutNatureNobel
Structure of the catalytic and antigenic sites in influenza virus neuraminidase
1983 Nature
A Novel Coronavirus from Patients with Pneumonia in China, 2019
2020 Standout
Does the higher order structure of the influenza virus ribonucleoprotein guide sequence rearrangements in influenza viral RNA?
1983 StandoutNobel
The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin
1995 StandoutNobel
Cytotoxic T cells recognize fragments of the influenza nucleoprotein
1985
Pulmonary complications of diabetes mellitus. Pneumonia.
1995
The structure of influenza virus
1970
Proteins of helper-dependent RSV
1971
Microbiota regulates immune defense against respiratory tract influenza A virus infection
2011 Standout
Airborne transmission of respiratory viruses
2021 StandoutScience
Cloning of influenza cDNA into M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein
1980 StandoutNobel
Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs
2008
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
2009
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout
Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses.
1977 StandoutNobel
PULMONARY COMPLICATIONS OF DIABETES MELLITUS
1995
THE ORIGINS OF NEW PANDEMIC VIRUSES: The Acquisition of New Host Ranges by Canine Parvovirus and Influenza A Viruses
2005
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of Alan Hampson being referenced
Influenza activity - United States and worldwide, 1999-2000 season, and composition of the 2000-01 influenza vaccine.
2000
Rapid detection and simultaneous subtype differentiation of influenza A viruses by real time PCR
2004
Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir
2004
Options for the control of influenza III
1997
An influenza A(H3) reassortant was epidemic in Australia and New Zealand in 2003
2005
Epidemiological data on influenza in Asian countries
1999
Reassortants in recent human influenza A and B isolates from South East Asia and Oceania
2003
Improving the selection and development of influenza vaccine viruses – Report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18–20 November 2015
2017
Low Incidence of Rimantadine Resistance in Field Isolates of Influenza A Viruses
1999
Effect of monoclonal anti-neuraminidase antibodies on the kinetic behaviour of influenza virus neuraminidase
1982
Annual report of the National Influenza Surveillance Scheme, 2002
2003
Anti-neuraminidase antibodies: Which substrate should be used to test their effect on influenza virus neuraminidase
1981
The polypeptides of influenza virus
1970
Influenza: dealing with a continually emerging disease
1996
The influenza viruses
2006
ANTIBODY RESPONSE TO ONE AND TWO DOSES OF INFLUENZA VIRUS SUBUNIT VACCINE
1962
Antibody Response in Humans to Deoxycholate-Treated Influenza Virus Vaccine
1968
Detection of Influenza Viruses Resistant to Neuraminidase Inhibitors in Global Surveillance during the First 3 Years of Their Use
2006
Influenza Immunization in Adults with Diabetes Mellitus
1983
The polypeptides of influenza virus
1970
The polypeptides of influenza virus
1969
The polypeptides of influenza virus
1970
Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir
2003